Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 16, 2017
A market evaluation by Future Market Insights highlights the small molecule API market in a new research study.
read more
Wednesday, August 30, 2017
Cambrex, announced it is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq.ft. analytical laboratory.
read more
Monday, September 25, 2017
Jaguar Health announced its wholly-owned subsidiary, Napo Pharmaceuticals, has entered into a Termination, Asset Transfer and Transition Agreement with India-based Glenmark Pharmaceuticals.
read more
Monday, September 25, 2017
Atox Bio today announced that it has been awarded the next option on a performance-based contract with the BARDA for the development of Reltecimod in patients with NSTI.
read more
Monday, September 25, 2017
Geisinger and Boehringer Ingelheim announced a collaboration to develop a risk-prediction model for three critical health outcomes commonly associated with type 2 diabetes that have long-term impact.
read more
Tuesday, October 03, 2017
Medicure announced it has sold its interests in Apicore to an arm's length, pharmaceutical company.
read more
The FDA awarded 15 new clinical trial research grants totaling more than $22 million to boost development of products for patients with rare diseases.
read more
Avara has signed and closed on an agreement with AstraZeneca to acquire the Reims, France manufacturing and distribution facility.
read more
Marken announced the acquisition of Touchdown International a privately held specialty logistics company in Taiwan, for an undisclosed sum.
read more
Tuesday, October 10, 2017
Protea Biosciences announced it plans to develop clinical screening assays in various areas of oncology.
read more
Tuesday, October 10, 2017
Pertinax Pharma announced the commercial launch of its proprietary Pertinax technology, which provides controlled and sustained delivery of CHX.
read more
Tuesday, October 10, 2017
Piramal announced investments of $55 million across its sites in North America & Asia, to expand its API manufacturing capabilities and capacities.
read more
Wednesday, October 11, 2017
CordenPharma has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from Pfizer.
read more
CordenPharma announces a strategic investment of €3.7 million in the manufacturing site infrastructure of its CordenPharma Switzerland facility, located in Liestal, Switzerland.
read more
AMRI will now offer its impurity solutions as a stand-alone service.
read more